CLPBF
Price
$96.80
Change
+$0.20 (+0.21%)
Updated
Aug 29 closing price
Capitalization
21.72B
CLPBY
Price
$9.67
Change
-$0.09 (-0.92%)
Updated
Sep 4 closing price
Capitalization
21.72B
59 days until earnings call
Interact to see
Advertisement

CLPBF vs CLPBY

Header iconCLPBF vs CLPBY Comparison
Open Charts CLPBF vs CLPBYBanner chart's image
Coloplast AS
Price$96.80
Change+$0.20 (+0.21%)
Volume$1
Capitalization21.72B
Coloplast AS
Price$9.67
Change-$0.09 (-0.92%)
Volume$160.46K
Capitalization21.72B
CLPBF vs CLPBY Comparison Chart in %
Loading...
CLPBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPBF vs. CLPBY commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPBF is a Hold and CLPBY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CLPBF: $96.80 vs. CLPBY: $9.67)
Brand notoriety: CLPBF and CLPBY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CLPBF: 0% vs. CLPBY: 69%
Market capitalization -- CLPBF: $21.72B vs. CLPBY: $21.72B
CLPBF [@Pharmaceuticals: Other] is valued at $21.72B. CLPBY’s [@Pharmaceuticals: Other] market capitalization is $21.72B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPBF’s FA Score shows that 1 FA rating(s) are green whileCLPBY’s FA Score has 1 green FA rating(s).

  • CLPBF’s FA Score: 1 green, 4 red.
  • CLPBY’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLPBF and CLPBY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPBF’s TA Score shows that 5 TA indicator(s) are bullish while CLPBY’s TA Score has 5 bullish TA indicator(s).

  • CLPBF’s TA Score: 5 bullish, 4 bearish.
  • CLPBY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CLPBY is a better buy in the short-term than CLPBF.

Price Growth

CLPBF (@Pharmaceuticals: Other) experienced а +0.21% price change this week, while CLPBY (@Pharmaceuticals: Other) price change was +1.15% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.39%. For the same industry, the average monthly price growth was +7.03%, and the average quarterly price growth was +18.51%.

Reported Earning Dates

CLPBY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLPBF($21.7B) and CLPBY($21.7B) have the same market capitalization . CLPBY (35.10) and CLPBF (34.26) have similar P/E ratio . CLPBY (-10.253) and CLPBF (-10.603) have similar YTD gains . CLPBF (8.66B) and CLPBY (8.66B) have comparable annual earnings (EBITDA) . CLPBF (729M) and CLPBY (729M) have equal amount of cash in the bank . CLPBF (24.3B) and CLPBY (24.3B) have identical debt. CLPBF (27.8B) and CLPBY (27.8B) have equivalent revenues.
CLPBFCLPBYCLPBF / CLPBY
Capitalization21.7B21.7B100%
EBITDA8.66B8.66B100%
Gain YTD-10.603-10.253103%
P/E Ratio34.2635.1098%
Revenue27.8B27.8B100%
Total Cash729M729M100%
Total Debt24.3B24.3B100%
FUNDAMENTALS RATINGS
CLPBF vs CLPBY: Fundamental Ratings
CLPBF
CLPBY
OUTLOOK RATING
1..100
8769
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
3535
PRICE GROWTH RATING
1..100
6060
P/E GROWTH RATING
1..100
7070
SEASONALITY SCORE
1..100
9090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPBF's Valuation (18) in the null industry is in the same range as CLPBY (18). This means that CLPBF’s stock grew similarly to CLPBY’s over the last 12 months.

CLPBF's Profit vs Risk Rating (100) in the null industry is in the same range as CLPBY (100). This means that CLPBF’s stock grew similarly to CLPBY’s over the last 12 months.

CLPBF's SMR Rating (35) in the null industry is in the same range as CLPBY (35). This means that CLPBF’s stock grew similarly to CLPBY’s over the last 12 months.

CLPBF's Price Growth Rating (60) in the null industry is in the same range as CLPBY (60). This means that CLPBF’s stock grew similarly to CLPBY’s over the last 12 months.

CLPBF's P/E Growth Rating (70) in the null industry is in the same range as CLPBY (70). This means that CLPBF’s stock grew similarly to CLPBY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPBFCLPBY
RSI
ODDS (%)
Bearish Trend 2 days ago
58%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
58%
Momentum
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 8 days ago
50%
Bullish Trend 8 days ago
60%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
56%
Aroon
ODDS (%)
Bullish Trend 2 days ago
46%
Bullish Trend 2 days ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
CLPBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLPBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RPAY5.690.09
+1.61%
Repay Holdings Corp
ATRA12.800.17
+1.35%
Atara Biotherapeutics Inc.
AQMS3.840.05
+1.32%
Aqua Metals Inc
COO68.000.86
+1.28%
Cooper Companies (The)
IDYA25.830.07
+0.27%
IDEAYA Biosciences

CLPBF and

Correlation & Price change

A.I.dvisor tells us that CLPBF and BLCO have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLPBF and BLCO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBF
1D Price
Change %
CLPBF100%
N/A
BLCO - CLPBF
22%
Poorly correlated
-0.27%
CLPBY - CLPBF
21%
Poorly correlated
-0.92%
CZMWF - CLPBF
13%
Poorly correlated
N/A
CZMWY - CLPBF
10%
Poorly correlated
-1.32%
BRSYF - CLPBF
7%
Poorly correlated
N/A
More

CLPBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBY has been loosely correlated with SMMNY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBY jumps, then SMMNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBY
1D Price
Change %
CLPBY100%
-0.92%
SMMNY - CLPBY
35%
Loosely correlated
+1.07%
SAUHY - CLPBY
35%
Loosely correlated
+1.89%
ESLOY - CLPBY
32%
Poorly correlated
+1.10%
WILLF - CLPBY
23%
Poorly correlated
N/A
AMBBY - CLPBY
23%
Poorly correlated
-1.93%
More